In a Q&A session on health complaints following COVID-19 vaccinations and infections, affected individuals report, among other things, persistent brain fog, which is associated with impaired blood circulation in the brain. A key cause is considered to be disrupted microcirculation, in which tiny blood clots block capillaries and thus impair the brain’s supply of oxygen and nutrients. Spike proteins may act as a trigger, as current research suggests that even small amounts can initiate the formation of such microthrombi. In addition, biochemical changes in the brain play a role, including imbalances in neurotransmitters, inflammatory processes, and disruptions of the glymphatic system, which normally removes waste products from the brain during sleep. Possible treatment approaches discussed include methods to improve circulation, certain dietary supplements, and medications such as selective serotonin reuptake inhibitors, with warnings against unsupervised use.
Another focus is on so-called small fiber neuropathy, which in affected individuals leads to sensory disturbances, pain, and in some cases permanent hair loss in specific areas of the body. In addition to circulatory problems, possible mechanisms include immunological processes in which antibodies mistakenly attack the body’s own nerve structures. Therapeutic approaches such as immunoglobulin treatments are discussed, although they are difficult to access and costly. A further aspect is the suspected link to ongoing production of spike proteins in the body, which can attach to cellular structures and promote inflammatory processes.
In addition, the formation of microclots is also discussed in connection with infections or so-called shedding effects, with individual case reports pointing to possible transmission phenomena. At the same time, it is emphasized that individual susceptibility varies greatly and that some people appear to remain asymptomatic. Measurements indicate that spike proteins can be detected in the blood of a significant proportion of asymptomatic individuals, suggesting ongoing production in the body, with recent samples showing that over 70 percent of tested symptom-free individuals were positive without provocation testing